Key Details
Price
$28.06PE Ratio
9.17Annual ROE
23.26%Beta
0.53Events Calendar
Next earnings date:
May 8, 2025Recent quarterly earnings:
Feb 27, 2025Recent annual earnings:
Feb 27, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 4, 25 Piper Sandler
NeutralNov 22, 24 Wells Fargo
OverweightAug 8, 24 Piper Sandler
OverweightAug 8, 24 Needham
HoldJun 27, 24 Piper Sandler
OverweightMay 22, 24 Needham
HoldMay 9, 24 Needham
HoldApr 10, 24 Needham
HoldMar 5, 24 JP Morgan
OverweightNov 17, 23 B of A Securities
NeutralMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Amphastar Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Amphastar Pharmaceuticals?
- Does Amphastar Pharmaceuticals pay dividends?
- What sector is Amphastar Pharmaceuticals in?
- What industry is Amphastar Pharmaceuticals in?
- What country is Amphastar Pharmaceuticals based in?
- When did Amphastar Pharmaceuticals go public?
- Is Amphastar Pharmaceuticals in the S&P 500?
- Is Amphastar Pharmaceuticals in the NASDAQ 100?
- Is Amphastar Pharmaceuticals in the Dow Jones?
- When was Amphastar Pharmaceuticals's last earnings report?
- When does Amphastar Pharmaceuticals report earnings?
- Should I buy Amphastar Pharmaceuticals stock now?
What is the ticker symbol for Amphastar Pharmaceuticals?
The ticker symbol for Amphastar Pharmaceuticals is NASDAQ:AMPH
Does Amphastar Pharmaceuticals pay dividends?
No, Amphastar Pharmaceuticals does not pay dividends
What sector is Amphastar Pharmaceuticals in?
Amphastar Pharmaceuticals is in the Healthcare sector
What industry is Amphastar Pharmaceuticals in?
Amphastar Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry
What country is Amphastar Pharmaceuticals based in?
Amphastar Pharmaceuticals is headquartered in United States
When did Amphastar Pharmaceuticals go public?
Amphastar Pharmaceuticals's initial public offering (IPO) was on June 25, 2014
Is Amphastar Pharmaceuticals in the S&P 500?
No, Amphastar Pharmaceuticals is not included in the S&P 500 index
Is Amphastar Pharmaceuticals in the NASDAQ 100?
No, Amphastar Pharmaceuticals is not included in the NASDAQ 100 index
Is Amphastar Pharmaceuticals in the Dow Jones?
No, Amphastar Pharmaceuticals is not included in the Dow Jones index
When was Amphastar Pharmaceuticals's last earnings report?
Amphastar Pharmaceuticals's most recent earnings report was on Feb 27, 2025
When does Amphastar Pharmaceuticals report earnings?
The next expected earnings date for Amphastar Pharmaceuticals is May 8, 2025
Should I buy Amphastar Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions